A major breakthrough in cancer investigation is arising with the use of nanobodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in several kinds of cancer, causing https://worldlistpro.com/story24051239/mini-antibodies-reactivate-tumor-suppressor-p53-a-promising-pathway-for-cancer-management